Connecticut 2021 2021 Regular Session

Connecticut Senate Bill SB00847 Introduced / Bill

Filed 02/04/2021

                        
 
 
LCO No. 2920  	1 of 4 
 
General Assembly  Raised Bill No. 847  
January Session, 2021 
LCO No. 2920 
 
 
Referred to Committee on PUBLIC HEALTH  
 
 
Introduced by:  
(PH)  
 
 
 
 
AN ACT CONCERNING NE WBORN INFANT HEALTH SCREENING. 
Be it enacted by the Senate and House of Representatives in General 
Assembly convened: 
 
Section 1. Section 19a-55 of the general statutes is repealed and the 1 
following is substituted in lieu thereof (Effective October 1, 2021): 2 
(a) The administrative officer or other person in charge of each 3 
institution caring for newborn infants shall cause to have administered 4 
to every such newborn infant in its care an HIV-related test, as defined 5 
in section 19a-581, a test for [phenylketonuria and other metabolic 6 
diseases] amino acid disorders, including phenylketonuria, organic acid 7 
disorders, fatty acid oxidation disorders, including, but not limited to, 8 
long-chain 3-hydroxyacyl CoA dehydrogenase (L -CHAD) and 9 
medium-chain acyl-CoA dehydrogenase (MCAD), hypothyroidism, 10 
galactosemia, sickle cell disease, maple syrup urine disease, 11 
homocystinuria, biotinidase deficiency, congenital adrenal hyperplasia, 12 
severe combined immunodeficiency disease, adrenoleukodystrophy 13 
and such other tests for [inborn errors of metabolism] other metabolic 14 
and genetic disorders included on the recommended uniform screening 15 
panel pursuant to 42 USC 300b-10, as amended from time to time, as 16  Raised Bill No.  847 
 
 
 
LCO No. 2920   	2 of 4 
 
[shall be] prescribed by the [Department] Commissioner of Public 17 
Health, [. The tests shall be administered as soon after birth as is 18 
medically appropriate] and subject to the approval of the Secretary of 19 
the Office of Policy and Management. 20 
(b) The testing requirements prescribed in subsection (a) of this 21 
section shall be performed using a blood spot specimen. The blood spot 22 
specimen shall be collected no earlier than twenty-four hours after the 23 
birth of the newborn infant and not later than forty-eight hours after the 24 
birth of such infant, unless the institution determines that a situation 25 
exists to warrant an early collection of the specimen or if collection of 26 
the specimen is medically contraindicated. Situations that warrant early 27 
collection of the specimen shall include, but shall not be limited to, the 28 
imminent transfusion of blood products, dialysis, early discharge of the 29 
newborn infant, transfer of the newborn infant to another institution, or 30 
imminent death. If the newborn infant dies before a blood spot specimen 31 
can be obtained, the specimen shall be collected as soon as practicable 32 
after death. The institution licensed to care for newborn infants, or a 33 
licensed nurse-midwife or midwife, shall notify the Department of 34 
Public Health when a specimen is not collected within forty-eight hours 35 
of birth due to medical fragility, refusal by the parents when newborn 36 
infant screening is in conflict with their religious tenets and practice, 37 
when a newborn infant is receiving comfort measures only, or for any 38 
other reason. Such notification shall be documented in the department's 39 
newborn screening system pursuant to section 19a-53 by the institution 40 
caring for newborn infants, nurse-midwife or midwife, or sent in 41 
writing to the department not later than seventy-two hours after the 42 
birth of the newborn infant. The institution caring for newborn infants 43 
or the nurse-midwife or midwife shall send the blood spot specimen to 44 
the state public health laboratory not later than twenty-four hours after 45 
the time of collection. The department may request an additional blood 46 
spot specimen if there was an early collection of the specimen or if the 47 
specimen was collected following a transfusion of blood products, if the 48 
specimen is unsatisfactory for testing or if the department determines 49 
that there is an abnormal result. If the mother has had an HIV-related 50  Raised Bill No.  847 
 
 
 
LCO No. 2920   	3 of 4 
 
test pursuant to section 19a-90 or 19a-593, the person responsible for 51 
testing under this section may omit an HIV-related test. 52 
(c) The Commissioner of Public Health shall (1) administer the 53 
newborn screening program, (2) direct persons identified through the 54 
screening program to appropriate specialty centers for treatments, 55 
consistent with any applicable confidentiality requirements, and (3) set 56 
the fees to be charged to institutions to cover all expenses of the 57 
comprehensive screening program including testing, tracking and 58 
treatment. The fees to be charged pursuant to subdivision (3) of this 59 
subsection shall be set at a minimum of ninety-eight dollars. The 60 
Commissioner of Public Health shall publish a list of all the abnormal 61 
conditions for which the department screens newborns under the 62 
newborn screening program. [, which shall include screening for amino 63 
acid disorders, organic acid disorders, fatty acid oxidation disorders, 64 
including, but not limited to, long-chain 3-hydroxyacyl CoA 65 
dehydrogenase (L-CHAD) and medium -chain acyl-CoA 66 
dehydrogenase (MCAD), and, subject to the approval of the Secretary 67 
of the Office of Policy and Management, any other disorder included on 68 
the recommended uniform screening panel pursuant to 42 USC 300b-10, 69 
as amended from time to time.] 70 
[(b)] (d) In addition to the testing requirements prescribed in 71 
subsection (a) of this section, the administrative officer or other person 72 
in charge of each institution caring for newborn infants, or a licensed 73 
nurse-midwife or midwife, shall cause to have administered to (1) every 74 
such infant in its care a screening test for (A) cystic fibrosis, and (B) 75 
critical congenital heart disease, [and (C) on and after January 1, 2020, 76 
spinal muscular atrophy,] and (2) any newborn infant who fails a 77 
newborn hearing screening, as described in section 19a-59, a screening 78 
test for cytomegalovirus, provided such screening test shall be 79 
administered within available appropriations. The administrative 80 
officer or other person in charge of each institution caring for newborn 81 
infants who performs the testing for critical congenital heart disease 82 
shall enter the results of such test into the newborn screening system 83 
pursuant to section 19a-53. The administrative officer or other person in 84  Raised Bill No.  847 
 
 
 
LCO No. 2920   	4 of 4 
 
charge of each institution who performs the testing for cystic fibrosis 85 
shall report the number of newborn infants screened and the aggregate 86 
results of such testing on an annual basis to the Department of Public 87 
Health, in a form and manner prescribed by the Commissioner of Public 88 
Health. The provisions of this section shall apply irrespective of the 89 
patient's insurance status or source of payment, including self-pay 90 
status. Such screening tests shall be administered as soon after birth as 91 
is medically appropriate. 92 
[(c)] (e) The administrative officer or other person in charge of each 93 
institution caring for newborn infants shall report any case of 94 
cytomegalovirus that is confirmed as a result of a screening test 95 
administered pursuant to subdivision (2) of subsection [(b)] (d) of this 96 
section to the Department of Public Health in a form and manner 97 
prescribed by the Commissioner of Public Health. 98 
[(d)] (f) The provisions of this section shall not apply to any infant 99 
whose parents object to the test or treatment as being in conflict with 100 
their religious tenets and practice. The commissioner shall adopt 101 
regulations, in accordance with the provisions of chapter 54, to 102 
implement the provisions of this section. 103 
This act shall take effect as follows and shall amend the following 
sections: 
 
Section 1 October 1, 2021 19a-55 
 
Statement of Purpose:   
To require health screening of newborn infants no earlier than twenty-
four hours after the birth of the newborn infant and not later than forty-
eight hours after the birth of such infant, and to add various metabolic 
and genetic disorders to the newborn infant screening panel. 
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except 
that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not 
underlined.]